about
The application of the open pharmacological concepts triple store (Open PHACTS) to support drug discovery researchThe ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptorGenome-scale screening of drug-target associations relevant to Ki using a chemogenomics approachEvolution of minimal specificity and promiscuity in steroid hormone receptorsChapter 7: PharmacogenomicsBitterDB: a database of bitter compoundsChemProt: a disease chemical biology databaseMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)Computational approaches in target identification and drug discoveryDrug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric DisordersSystems Pharmacology in Small Molecular Drug DiscoveryIntegrating Multiscale Modeling with Drug Effects for Cancer TreatmentLeveraging big data to transform target selection and drug discoveryPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesNetwork-based approaches in drug discovery and early developmentEffects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature reviewDREADDs: novel tools for drug discovery and developmentLinked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatmentsComputational methods in drug discoveryCholinergic modulation by opioid receptor ligands: potential application to Alzheimer's diseaseTranslational bioinformatics: linking the molecular world to the clinical worldA survey on the computational approaches to identify drug targets in the postgenomic eraStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewRecent advances in the neuropsychopharmacology of serotonergic hallucinogensMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryIn silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feedingComplementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain InhibitorsInhibition of Antibiotic-Resistant Staphylococcus aureus by the Broad-Spectrum Dihydrofolate Reductase Inhibitor RAB1Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties.DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learningA multi-label approach to target prediction taking ligand promiscuity into accountAccurate and efficient target prediction using a potency-sensitive influence-relevance voterImproving chemical similarity ensemble approach in target predictionBioTriangle: a web-accessible platform for generating various molecular representations for chemicals, proteins, DNAs/RNAs and their interactionsTarget prediction utilising negative bioactivity data covering large chemical spaceLeveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associationsDASPfind: new efficient method to predict drug–target interactionsEpigenetic polypharmacology: from combination therapy to multitargeted drugsGenome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders
P2860
Q19845588-91403238-8D68-40C2-884D-783298C610EEQ21089799-14DF98C4-067C-44DA-9737-F191B924B957Q21133651-BC7DF9A9-22C0-4071-9C86-7872BE9764CEQ21144901-CDEFE7DE-BAB5-42E2-AFA2-A3EBBB252706Q21563496-F649F8FC-3308-4A82-BC0F-67B9B12FEFBFQ22337123-335AAD13-5416-43C7-989A-4763A07EC2B8Q24608769-57D7FA11-4C10-48DF-8D30-DB15D6CB41A5Q24620764-9C636A4A-DE6C-4A0D-AF41-443B3A0E47FEQ24634179-B29EC20B-D653-4118-BC0D-B7264AAD3A9FQ26746941-98E90CA1-89B4-49EB-855E-1D5B0A21D383Q26748728-6E43B01F-9EA7-43CC-B4DE-5E717B3CB523Q26768459-A101264E-7B67-4634-A87B-528F00E20104Q26770510-690CDA0D-EF74-48AF-8E41-895AA3325CE4Q26776403-1A40184E-FA75-4582-B703-80B105D25B06Q26799997-AFC59C27-4C06-49C4-949B-B3758CCA0345Q26827940-8DCFA76B-DEED-4DC8-9389-3B122F14D7AAQ26860175-4D51C446-60F9-415E-9D07-D51EF41E0C7CQ26995396-B9656EC5-E19D-42A5-AD78-DEDF89C2C32FQ26995786-31714BA6-91D9-4BC8-B876-DA81EE508EA9Q26997089-F386EB38-5964-4BF9-82D5-BBA670A25493Q26999066-02637C4C-B1FA-4509-990A-57B49C5C478DQ27002440-16CCA07D-ED43-4E36-A70F-1C509961D3BEQ27003870-703C51C3-A280-4B8E-8A96-6378CF324385Q27008867-0DF9B538-DDF6-412B-B3A2-B4FA6429DA19Q27027381-9DD704E9-1CB1-4856-9A40-FA86B2FF4F6CQ27144251-12B3C271-082E-4919-B1A2-EF4AB71A5573Q27316596-96FBAF99-5666-4622-9B57-5F88E6874B2EQ27662173-3E12DD8A-8961-417C-AA63-7546E9100218Q27663178-6B8C718C-F8D2-4C45-BE31-60850A18C341Q27690887-CD5FCD73-90D1-4128-BC11-24A28F7AB673Q27902260-BBDFB392-EF5F-4645-9EEE-53EF3CF7F821Q27902280-60159420-4072-40EF-B1ED-2609B4825D36Q27902298-35D55CF9-5467-48ED-ABE2-6B2E65351448Q27902303-5A43D768-4AF8-494E-93C9-0D0DC6465940Q27902315-2ADEB389-D929-44F7-9960-0EEB217C8511Q27902317-0AD1096A-36F6-432A-9B90-2B8909AA0679Q27902320-D0CF94F5-9A3D-4CC2-BAA9-6CAF63BA0B0BQ27902360-35C3D146-C0C0-497B-80F9-4755346A96AFQ28067666-D034726E-10C7-4869-A675-2767ED77752FQ28082561-C64F25AF-057F-4C3B-8D85-FE31C01FD72A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Predicting new molecular targets for known drugs
@ast
Predicting new molecular targets for known drugs
@en
Predicting new molecular targets for known drugs
@nl
type
label
Predicting new molecular targets for known drugs
@ast
Predicting new molecular targets for known drugs
@en
Predicting new molecular targets for known drugs
@nl
prefLabel
Predicting new molecular targets for known drugs
@ast
Predicting new molecular targets for known drugs
@en
Predicting new molecular targets for known drugs
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Predicting new molecular targets for known drugs
@en
P2093
Atheir I Abbas
Brian K Shoichet
Bryan L Roth
Christian Laggner
Douglas D Edwards
Michael B Kuijer
Niels H Jensen
Richard A Glennon
Roberto C Matos
Ryan Whaley
P2860
P2888
P304
P3181
P356
10.1038/NATURE08506
P407
P577
2009-11-01T00:00:00Z
P5875
P6179
1002283105